This study aimed to assess the real cost-effectiveness of DES using prospectively collected outcome data from consecutive patients in the immediate pre-DES era.
A prospective database on all percutaneous coronary interventions (PCI) performed by one operator in the two years prior to DES introduction (July 2000–June 2002) was used in which 12-month follow-up was complete in 96%. In 490 patients, 510 PCI were undertaken on 650 lesions (298 ‘high risk’) using 686 stents.
Published in the Heart, Lung and Circulation
Keywords: Stent; Drug-eluting; Coronary intervention; Restenosis; Cost-effectiveness
